Related Experiment Video
Updated: May 23, 2026

Assaying Protein Kinase Activity with Radiolabeled ATP
Published on: May 26, 2017
PRKAR1A gene analysis and protein kinase A activity in endometrial tumors
A Tsigginou1, E Bimpaki, M Nesterova
1First Department of Obstetrics and Gynecology, Athens University Medical School, Alexandra Hospital, 115 28 Athens, Greece.
Abstract:
PRKAR1A codes for the type 1a regulatory subunit (RIα) of the cAMP-dependent protein kinase A (PKA), an enzyme with an important role in cell cycle regulation and proliferation. PKA dysregulation has been found in various tumors, and PRKAR1A-inactivating mutations have been reported in mostly endocrine neoplasias. In this study, we investigated PKA activity and the PRKAR1A gene in normal and tumor endometrium. Specimens were collected from 31 patients with endometrial cancer. We used as controls 41 samples of endometrium that were collected from surrounding normal tissues or from women undergoing gynecological operations for other reasons. In all samples, we sequenced the PRKAR1A-coding sequence and studied PKA subunit expression; we also determined PKA activity and cAMP binding. PRKAR1A mutations were not found. However, PKA regulatory subunit protein levels, both RIα and those of regulatory subunit type 2b (RIIβ), were lower in tumor samples; cAMP binding was also lower in tumors compared with normal endometrium (P<0.01). Free PKA activity was higher in tumor samples compared with that of control tissue (P<0.01). There are significant PKA enzymatic abnormalities in tumors of the endometrium compared with surrounding normal tissue; as these were not due to PRKAR1A mutations, other mechanisms affecting PKA function ought to be explored.
Insights
Endometrial tumors show altered protein kinase A (PKA) activity, with lower regulatory subunit levels and increased free PKA activity, despite no PRKAR1A mutations. Further research is needed to understand these PKA dysregulations in endometrial cancer.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- The cAMP-dependent protein kinase A (PKA) is crucial for cell cycle regulation and proliferation.
- Dysregulation of PKA is implicated in various cancers.
- PRKAR1A mutations are linked to endocrine neoplasias, but their role in endometrial cancer is unclear.
Purpose of the Study:
- To investigate PKA activity and the PRKAR1A gene in normal and cancerous endometrial tissues.
- To determine if PRKAR1A mutations are present in endometrial cancer.
- To assess PKA subunit expression, activity, and cAMP binding in endometrial tumors.
Main Methods:
- PRKAR1A gene sequencing in 31 endometrial cancer samples and 41 controls.
- Analysis of PKA subunit expression (RIα and RIIβ).
- Measurement of PKA activity and cAMP binding.
Main Results:
- No PRKAR1A mutations were detected in the studied endometrial samples.
- Lower levels of PKA regulatory subunits (RIα and RIIβ) were observed in tumor tissues.
- Reduced cAMP binding and increased free PKA activity were found in endometrial tumors compared to normal tissues.
Conclusions:
- Endometrial tumors exhibit significant PKA enzymatic abnormalities.
- These abnormalities are not caused by PRKAR1A mutations.
- Alternative mechanisms influencing PKA function in endometrial cancer require investigation.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
PI3K/mTOR/AKT Signaling Pathway